In children, it is most commonly associated with sulfa drugs and anticonvulsants.1 Typically, the clinical picture develops between 4 and 28 days (most frequently 1015 days) after starting treatment.2 Involvement of the oral, ocular, gastrointestinal, and genital mucosa is very common.1 The incidence of EN and the associated mortality appear to be lower in children than adults
Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein
When do I feel effects
Hald Albertsen C, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB
Genomic heterogeneity of lung cancers and its potential clinical implications
B12: Essential for myelin synthesis and nerve function, addressing deficiencies linked to migraine frequency and neurological symptoms